Storm Therapeutics

OverviewSuggest Edit

Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. 
Several large families of RNA-modifying enzymes have been identified that impact key biological processes by changing the activity of RNA through catalysing epigenetic RNA modifications. Advances in the understanding of RNA modification and its role in the development of cancer offer the prospect of exploring novel therapeutic targets and potential discovery and development of first-in-class products. STORM is working in this new field.

TypePrivate
Founded2015
HQCambridge, GB
Websitestormtherapeutics.com

Locations

Storm Therapeutics is headquartered in
Cambridge, United Kingdom

Location Map

Latest Updates

Employees (est.) (Jan 2020)29

Key People/Management at Storm Therapeutics

Keith Blundy

Keith Blundy

Director and Chief Executive Officer
Oliver Rausch

Oliver Rausch

Chief Scientific Officer
Wesley Blackaby

Wesley Blackaby

Vice President of Chemistry
Mark Albertella

Mark Albertella

VP of Translational Oncology
Tim Edwards

Tim Edwards

Chairman of the Board
Eric Miska

Eric Miska

Founder & Director
Show more

Storm Therapeutics Office Locations

Storm Therapeutics has offices in Cambridge and Greater London
Cambridge, GB (HQ)
Babraham Research Campus
Greater London, GB
9 Devonshire Square
Show all (2)

Storm Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2015

Storm Therapeutics total Funding

$21.4 m

Storm Therapeutics latest funding size

$5.40 m

Time since last funding

2 years ago

Storm Therapeutics investors

Storm Therapeutics's latest funding round in January 2018 was reported to be $5.4 m. In total, Storm Therapeutics has raised $21.4 m
Show all financial metrics

Storm Therapeutics Revenue

Cash (31-Dec-2018)

4.9m
GBPFY, 2015FY, 2016FY, 2017FY, 2018

Cash

481.3k2.4m5.7m4.9m

Current Assets

504.0k3.0m7.0m7.0m
Y, 2018

Financial Leverage

1.2 x
Show all financial metrics

Storm Therapeutics Online and Social Media Presence

Embed Graph

Storm Therapeutics Frequently Asked Questions

  • When was Storm Therapeutics founded?

    Storm Therapeutics was founded in 2015.

  • Who are Storm Therapeutics key executives?

    Storm Therapeutics's key executives are Keith Blundy, Oliver Rausch and Wesley Blackaby.

  • How many employees does Storm Therapeutics have?

    Storm Therapeutics has 29 employees.

  • Who are Storm Therapeutics competitors?

    Competitors of Storm Therapeutics include Sareum Holdings, Cybrexa Therapeutics and Tiltan Pharma.

  • Where is Storm Therapeutics headquarters?

    Storm Therapeutics headquarters is located at Babraham Research Campus, Cambridge.

  • Where are Storm Therapeutics offices?

    Storm Therapeutics has offices in Cambridge and Greater London.

  • How many offices does Storm Therapeutics have?

    Storm Therapeutics has 2 offices.